[{"Assets_0_Q3_USD":1757995000.0,"CommonStockSharesOutstanding_0_Q3_shares":157496990.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":30007000.0,"NetIncomeLoss_1_Q3_USD":-52878000.0,"NetIncomeLoss_3_Q3_USD":-191266000.0,"StockholdersEquity_0_Q3_USD":1068184000.0,"Ticker":"ALKS","CIK":"1520262","name":"ALKERMES PLC.","OfficialName":"Alkermes plc Ordinary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4612884468.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191023"}]